Last week’s pick, Brooklyn ImmunoTherapeutics (NYSE: BTX), went from $4.67 on last Monday’s closing, to $8.53 the next day (up 83%). Check out our latest pick in this report.
The U.S. Fed’s Chair, Jerome Powell, stated yesterday that the economy is at an inflection point, with stronger growth and job creation ahead.Eight of the top 15 hardest hit nations continued to report WoW increases in new COVID-19 cases last week. On a positive note, highly vaccinated nations such as the U.S., the U.K., and Israel, are reporting flat or declines in new cases.
With rising inflation expectations, and the Fed showing no signs of raising rates this year, we remain bullish on gold. In addition to gold, we expect nickel prices to be higher by the year-end.
Microsoft is acquiring Nuance Communications (Nasdaq: NUAN) for US$19.7B. Check out our analysts’ thoughts on this deal.
Over the past week, Canopy (TSX: WEED) announced it will be acquiring Supreme (TSX: FIRE) for $435M. As all other large Canadian cannabis players have announced M&A deals in 2021, we expect Aurora (TSX: ACB) and Cronos (TSX: CRON) to seek similar opportunities in the near-term
